sb 203580 has been researched along with 3,4-dihydroxyphenylethanol in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (3,4-dihydroxyphenylethanol) | Trials (3,4-dihydroxyphenylethanol) | Recent Studies (post-2010) (3,4-dihydroxyphenylethanol) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 860 | 37 | 643 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borriello, A; Criniti, V; Cucciolla, V; Della Ragione, F; Indaco, S; Zappia, V | 1 |
1 other study(ies) available for sb 203580 and 3,4-dihydroxyphenylethanol
| Article | Year |
|---|---|
Antioxidants induce different phenotypes by a distinct modulation of signal transduction.
Topics: Antioxidants; Apoptosis; DNA-Binding Proteins; DNA, Complementary; Early Growth Response Protein 1; Enzyme Inhibitors; Flavonoids; HL-60 Cells; Humans; Imidazoles; Immediate-Early Proteins; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Models, Chemical; Phenotype; Phenylethyl Alcohol; Phosphorylation; Proto-Oncogene Proteins c-jun; Pyridines; Pyrrolidines; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes; Thiocarbamates; Time Factors; Transcription Factors; Up-Regulation | 2002 |